DTNA antibody
Quick Overview for DTNA antibody (ABIN2719779)
Target
See all DTNA AntibodiesReactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Characteristics
- Homo sapiens dystrobrevin, alpha (DTNA), transcript variant 5
-
Purification
- Purified from mouse ascites fluids by affinity chromatography
-
Immunogen
- Full length human recombinant protein of human DTNA (NP_116761) produced in HEK293T cell.
-
Isotype
- IgG2a
-
-
-
-
Application Notes
- WB 1:2000, IF 1:100, FLOW 1:100
-
Comment
-
The concentration of the product may vary between diferrent lots.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.5-1.0 mg/mL
-
Buffer
- PBS (PH 7.3) containing 1 % BSA, 50 % glycerol and 0.02 % sodium azide.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C
-
-
- DTNA (Dystrobrevin alpha (DTNA))
-
Alternative Name
- DTNA
-
Background
- The protein encoded by this gene belongs to the dystrobrevin subfamily of the dystrophin family. This protein is a component of the dystrophin-associated protein complex (DPC), which consists of dystrophin and several integral and peripheral membrane proteins, including dystroglycans, sarcoglycans, syntrophins and alpha- and beta-dystrobrevin. The DPC localizes to the sarcolemma and its disruption is associated with various forms of muscular dystrophy. Mutations in this gene are associated with left ventricular noncompaction with congenital heart defects. Multiple alternatively spliced transcript variants encoding different isoforms have been identified for this gene.
-
Molecular Weight
- 58.7 kDa
-
Gene ID
- 1837
-
NCBI Accession
- NM_032979
-
HGNC
- 1837
Target
-